KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Capital Expenditures (2019 - 2026)

GoodRx Holdings' Capital Expenditures history spans 7 years, with the latest figure at $14.6 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 8905.56% to $14.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.5 million, a 5585.4% increase, with the full-year FY2025 number at $70.5 million, up 5585.4% from a year prior.
  • Capital Expenditures hit $14.6 million in Q4 2025 for GoodRx Holdings, down from $55.4 million in the prior quarter.
  • Over the last five years, Capital Expenditures for GDRX hit a ceiling of $55.4 million in Q3 2025 and a floor of -$13.7 million in Q2 2023.
  • Historically, Capital Expenditures has averaged $10.4 million across 5 years, with a median of $4.4 million in 2021.
  • Biggest five-year swings in Capital Expenditures: crashed 454.93% in 2021 and later surged 13641.44% in 2025.
  • Tracing GDRX's Capital Expenditures over 5 years: stood at $26.1 million in 2021, then plummeted by 42.04% to $15.1 million in 2022, then fell by 17.68% to $12.5 million in 2023, then tumbled by 98.7% to $162000.0 in 2024, then skyrocketed by 8905.56% to $14.6 million in 2025.
  • Business Quant data shows Capital Expenditures for GDRX at $14.6 million in Q4 2025, $55.4 million in Q3 2025, and $390000.0 in Q2 2025.